The UK Life Sciences Ecosystem: A Snapshot

Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in close adjacency to the most successful basic science programmes in biomedicinein the world. The co-location of pharmaceutical discovery sciences adjacent to the best universities (AstraZeneca in Cambridge, Novo Nordisk in Oxford) highlights the importance of sustaining their competitive position.

Similar Facts and Figures

Latest Reports